medroxyprogesterone acetate has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crandall, CJ; Manson, JE; Mehta, JM | 1 |
| Ekholm, E; Kuusela, T; Polo, O; Polo-Kantola, P; Saaresranta, T; Virtanen, I | 1 |
1 review(s) available for medroxyprogesterone acetate and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Management of Menopausal Symptoms: A Review.
Topics: Autonomic Nervous System Diseases; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasms; Paroxetine; Sweating; Venlafaxine Hydrochloride; Venous Thromboembolism | 2023 |
1 other study(ies) available for medroxyprogesterone acetate and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Medroxyprogesterone improves cardiac autonomic control in postmenopausal women with respiratory insufficiency.
Topics: Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Contraceptive Agents, Female; Female; Forced Expiratory Volume; Heart Rate; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Prospective Studies; Respiratory Insufficiency; Single-Blind Method | 2004 |